Minireview: Effects of Different HT Formulations on Cognition (Q38016689)

27 August 2017

title

Minireview: effects of different HT formulations on cognition (English)

1 reference

https://api.crossref.org/works/10.1210/EN.2012-1175

27 August 2017

Minireview: Effects of Different HT Formulations on Cognition (English)

1 reference

3 January 2025

1

Pauline M Maki

1 reference

27 August 2017

language of work or name

English

0 references

publication date

6 June 2012

1 reference

27 August 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Endocrinology

1 reference

27 August 2017

volume

153

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

3564-3570

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

27 August 2017

cites work

https://api.crossref.org/works/10.1210/EN.2012-1175

1

1 reference

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

2

1 reference

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

3

1 reference

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

4

1 reference

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

5

1 reference

Sex steroids to maintain cognitive function in women after the menopause: a meta-analyses of treatment trials

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

6

1 reference

The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

8

1 reference

Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

9

1 reference

Neuropsychological measures in normal individuals that predict subsequent cognitive decline.

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

10

1 reference

Aging, estrogens, and episodic memory in women

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

11

1 reference

Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

12

1 reference

Effects of combination estrogen plus progestin hormone treatment on cognition and affect

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

13

1 reference

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

14

1 reference

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

15

1 reference

Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

17

1 reference

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

18

1 reference

KEEPS: The Kronos Early Estrogen Prevention Study

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

19

1 reference

Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

20

1 reference

Effects of botanicals and combined hormone therapy on cognition in postmenopausal women.

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

21

1 reference

Estrogen progestin therapy and cognition: a randomized placebo-controlled double-blind study

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

23

1 reference

A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

24

1 reference

Clinically Relevant Progestins Regulate Neurogenic and Neuroprotective Responses in Vitro and in Vivo

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

25

1 reference

Medroxyprogesterone acetate antagonizes estrogen up-regulation of brain mitochondrial function

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

26

1 reference

Impact of progestins on estradiol potentiation of the glutamate calcium response

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

27

1 reference

Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

28

1 reference

Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

29

1 reference

Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST).

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

30

1 reference

A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

31

1 reference

The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

32

1 reference

Effects of estrogen on memory function in surgically menopausal women

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

33

1 reference

Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

34

1 reference

Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

35

1 reference

Hot flashes and estrogen therapy do not influence cognition in early menopausal women

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

36

1 reference

Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

37

1 reference

Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

38

1 reference

Differences in Verbal Memory Performance in Postmenopausal Women Receiving Hormone Therapy: 17β-Estradiol Versus Conjugated Equine Estrogens

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

39

1 reference

Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD.

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

40

1 reference

Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study.

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

41

1 reference

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

42

1 reference

Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

43

1 reference

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

44

1 reference

Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

45

1 reference

The 2012 Hormone Therapy Position Statement of The North American Menopause Society

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

46

1 reference

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

47

1 reference

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

48

1 reference

Premature menopause or early menopause: long-term health consequences

3 January 2025

https://api.crossref.org/works/10.1210/EN.2012-1175

49

1 reference

3 January 2025

Identifiers

DOI

10.1210/EN.2012-1175

1 reference

27 August 2017

1 reference